Dateline City:
KENILWORTH, N.J.
KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada,
announced today that Dr. Roger M. Perlmutter, president, Merck Research
Laboratories, will present an overview of the companys oncology program
at the 52nd Annual Meeting of the American Society of Clinical Oncology
(ASCO) in Chicago on June 6, 2016 at 5:45 p.m. CDT (6:45 p.m. EDT).
Language:
English
Contact:
MerckMedia:Lainie Keller, (908) 236-5036orInvestor:Teri Loxam, (908) 740-1986orJustin Holko, (908) 740-1879
Ticker Slug:
Ticker: MRK Exchange: NYSE
read more